Skip to main content
NCBI home page
Gut logoLink to Gut
. 1976 Jul;17(7):495–500. doi: 10.1136/gut.17.7.495

Antibiotics in biliary disease: the relative importance of antibiotic concentrations in the bile and serum.

M R Keighley, R B Drysdale, A H Quoraishi, D W Burdon, J Alexander-Willians
PMCID: PMC1411162  PMID: 786807

Abstract

A randomised controlled trial has been performed in 150 patients undergoing biliary operations to determine whether an antibiotic which is excreted almost entirely in bile (rifamide) is to be preferred to one having satisfactory serum levels only (gentamicin). Patients were allocated to one of three groups: 50 received gentamicin, 50 received rifamide, and there were 50 controls who received no antibiotic cover. In the absence of duct obstruction, rifamide achieved extremely high bile levels but low serum concentrations. However, in jaundiced patients, both the bile and the serum concentrations of rifamide were too low to be of therapeutic value. The incidence of postoperative sepsis was not reduced by rifamide compared with controls. In contrast, gentamicin achieved adequate serum concentrations in 88% of patients. Despire poor bile levels, gentamicin was associated with a significant reduction of wound infection from 22% to 6% and septicaemia from 14% to 2% compared with controls. To reduce the septic complications of biliary operations, adequate serum levels of an effective antimicrobial are more important than an antibiotic, which is excreted almost entirely into the bile.

Full text

PDF
495

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Acocella G., Mattiussi R., Nicolis F. B., Pallanza R., Tenconi L. T. Biliary excretion of antibiotics in man. Gut. 1968 Oct;9(5):536–545. doi: 10.1136/gut.9.5.536. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bevan P. G., Williams J. D. Rifamide in acute cholecystitis and biliary surgery. Br Med J. 1971 Jul 31;3(5769):284–287. doi: 10.1136/bmj.3.5769.284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. EDLUND Y. A., MOLLSTEDT B. O., OUCHTERLONY O. Bacteriological investigation of the biliary system and liver in biliary tract disease correlated to clinical data and microstructure of the gallbladder and liver. Acta Chir Scand. 1959 May 15;116(5-6):461–476. [PubMed] [Google Scholar]
  4. Engström J., Hellström K., Högman L., Lönnqvist B. Microorganisms of the liver, biliary tract and duodenal aspirates in biliary diseases. Scand J Gastroenterol. 1971;6(2):177–182. doi: 10.3109/00365527109180689. [DOI] [PubMed] [Google Scholar]
  5. Flemma R. J., Flint L. M., Osterhout S., Shingleton W. W. Bacteriologic studies of biliary tract infection. Ann Surg. 1967 Oct;166(4):563–572. doi: 10.1097/00000658-196710000-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Keighley M. R., Baddeley R. M., Burdon D. W., Edwards J. A., Quoraishi A. H. A controlled trial of parenteral prophylactic gentamicin therapy in biliary surgery. Br J Surg. 1975 Apr;62(4):275–279. doi: 10.1002/bjs.1800620406. [DOI] [PubMed] [Google Scholar]
  7. Keighley M. R., Lister D. M., Jacobs S. I., Giles G. R. Hazards of surgical treatment due to microorganisms in the bile. Surgery. 1974 Apr;75(4):578–583. [PubMed] [Google Scholar]
  8. Khan G. A., Scott A. J. The place of rifamycin-B-diethylamide in the treatment of cholangitis complicating biliary obstruction. Br J Pharmacol Chemother. 1967 Nov;31(3):506–512. doi: 10.1111/j.1476-5381.1967.tb00415.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Maddocks A. C., Hilson G. R., Taylor R. The bacteriology of the obstructed biliary tree. Ann R Coll Surg Engl. 1973 May;52(5):316–319. [PMC free article] [PubMed] [Google Scholar]
  10. Mason G. R. Bacteriology and antibiotic selection in biliary tract surgery. Arch Surg. 1968 Oct;97(4):533–537. doi: 10.1001/archsurg.1968.01340040029002. [DOI] [PubMed] [Google Scholar]
  11. Mortimer P. R., Mackie D. B., Haynes S. Ampicillin levels in human bile in the presence of biliary tract disease. Br Med J. 1969 Jul 12;3(5662):88–89. doi: 10.1136/bmj.3.5662.88. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. ZASLOW J., HEWLETT T. H., LORRY R. W. The excretion and concentration of aureomycin in the abnormal human biliary tract. Gastroenterology. 1950 Oct;16(2):475–478. [PubMed] [Google Scholar]
  13. ZASLOW J., ROSENTHAL A. The excretion and concentration of terramycin in the abnormal human biliary tract. Ann Surg. 1954 Apr;139(4):478–483. doi: 10.1097/00000658-195404000-00012. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES